News
ScienceAlert on MSN20h
Scientists May Have Identified a Natural Alternative to Ozempic
Glucagon-like peptide-1 (GLP-1) is a hormone that is naturally produced by the body and which helps regulate blood sugar ...
Enzalutamide and other ARPIs are key in treating metastatic prostate cancer by blocking androgen receptors, improving patient ...
inews.co.uk on MSN2d
My mum had Alzheimer’s – this is what I’m doing to reduce my risk
From taking HRT to eating a healthy diet, Kate Muir shares some of the precautionary measures she's trying to avoid ...
Celcuity (CELC), a clinical-stage biotechnology company, has quietly surged more than 215% year-to-date, turning heads on ...
Stockhead on MSN13d
Doubling up: How ASX biotechs are multiplying their impact
ASX companies such as LTR Pharma are finding smarter ways to stretch the value of existing assets and launch into broader ...
The AI-driven collaboration will use Syntekabio’s DeepMatcher platform to identify new therapeutic targets for MetaVia’s ...
Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.
Discover the latest breakthroughs in oncology, including FDA approvals and innovative therapies reshaping cancer treatment ...
Chemical sunscreens absorb UV radiation, converting it into heat and releasing it from the skin. Mineral sunscreens, ...
Roche’s Itovebi gets European approval to treat people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutation: Basel Thursday, July 24, 2025, 09:00 Hrs [ ...
In July 2025, Clinuvel Inc. conducted a CUV105 study will assess the efficacy and safety of afamelanotide and NB-UVB light in ...
Click here to view the custom infographic of the Soligenix Inc. editorial. Clickhere to view the custom infographic of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback